Product Overview
Brivaracetam API (357336-20-0) is the high-affinity synaptic vesicle protein 2A (SV2A) ligand.
It functions as an antiepileptic drug (AED).
Mainly, Brivaracetam is developed as an analog of levetiracetam.
The role is seen towards the adjunctive therapy in the action of partial onset seizures in patients.
Therapeutic Applications
Epilepsy is treated as adjunctive therapy for partial-onset seizures.
Neuropsychiatric Conditions in treating generalised seizures, anxiety disorders, and neuropathic pain.
Comes with a favourable CNS safety profile.
Specification Parameters
-
The white off-white crystalline powder is the appearance of Brivaracetam (357336-20-0).
-
The melting point is 74°C – 78°C.
-
Water Content (KF)≤ 0.5%
-
Heavy metals are ≤ 10 ppm
-
The related substance is Total impurities ≤ 1.0%
-
Identification conforms to the reference standard.
Packaging & Storage
Available in 1g / 5g / 25g / 100g / 1kg in HDPE bottles.
The bulk packaging is done in fibre drums with double polyethylene liners
Why Choose Us
Following GMP & ISO-certified facilities and maintaining the quality of products.
Ensure complete regulatory support.
Offers custom synthesis available as per the customer’s demand.
Helps in the international delivery system.
Offering competitive pricing for all products.
